Detalhe da pesquisa
1.
Tumor residue in patients with stage II-IVA nasopharyngeal carcinoma who received intensity-modulated radiation therapy: development and validation of a prediction nomogram integrating postradiotherapy plasma Epstein-Barr virus deoxyribonucleic acid, clinical stage, and radiotherapy dose.
BMC Cancer
; 23(1): 410, 2023 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37149594
2.
Widely targeted quantitative lipidomics and prognostic model reveal plasma lipid predictors for nasopharyngeal carcinoma.
Lipids Health Dis
; 22(1): 81, 2023 Jun 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37365637
3.
Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage III-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised, controlled, phase 3 trial.
Lancet Oncol
; 22(5): 716-726, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33857411
4.
Safety and efficacy of lobaplatin combined with 5-fluorouracil as first-line induction chemotherapy followed by lobaplatin-radiotherapy in locally advanced nasopharyngeal carcinoma: preliminary results of a prospective phase II trial.
BMC Cancer
; 17(1): 134, 2017 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28202000
5.
Camrelizumab and apatinib plus induction chemotherapy and concurrent chemoradiotherapy in stage N3 nasopharyngeal carcinoma: a phase 2 clinical trial.
Nat Commun
; 15(1): 1029, 2024 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38310101
6.
Toripalimab plus capecitabine in the treatment of patients with residual nasopharyngeal carcinoma: a single-arm phase 2 trial.
Nat Commun
; 15(1): 949, 2024 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38297016
7.
Nab-paclitaxel, cisplatin, and capecitabine versus cisplatin and gemcitabine as first line chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma: randomised phase 3 clinical trial.
BMJ
; 385: e077890, 2024 06 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38897625
8.
Efficacy and safety of sintilimab plus bevacizumab in metastatic nasopharyngeal carcinoma after failure of platinum-based chemotherapy: an open-label phase 2 study.
EClinicalMedicine
; 62: 102136, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37593221
9.
A deep learning-based semiautomated workflow for triaging follow-up MR scans in treated nasopharyngeal carcinoma.
iScience
; 26(12): 108347, 2023 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38125021
10.
Effect of Capecitabine Maintenance Therapy Plus Best Supportive Care vs Best Supportive Care Alone on Progression-Free Survival Among Patients With Newly Diagnosed Metastatic Nasopharyngeal Carcinoma Who Had Received Induction Chemotherapy: A Phase 3 Randomized Clinical Trial.
JAMA Oncol
; 8(4): 553-561, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35175316
11.
Effect of Induction Chemotherapy With Paclitaxel, Cisplatin, and Capecitabine vs Cisplatin and Fluorouracil on Failure-Free Survival for Patients With Stage IVA to IVB Nasopharyngeal Carcinoma: A Multicenter Phase 3 Randomized Clinical Trial.
JAMA Oncol
; 8(5): 706-714, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35323856
12.
A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer.
Clin Cancer Res
; 27(15): 4186-4194, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34083231
13.
Prognostic value of early radiological response to first-line platinum-containing chemotherapy in patients with metastatic nasopharyngeal carcinoma.
Cancer Med
; 9(3): 920-930, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31834990
14.
MRI-detected residual retropharyngeal lymph node after intensity-modulated radiotherapy in nasopharyngeal carcinoma: Prognostic value and a nomogram for the pretherapy prediction of it.
Radiother Oncol
; 145: 101-108, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31931288
15.
Stage-specific concurrent chemoradiotherapy with or without induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma: a retrospective, population-based study.
Cancer Manag Res
; 11: 9813-9827, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31819619
16.
The CXCL5/CXCR2 axis contributes to the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells by activating ERK/GSK-3ß/snail signalling.
J Exp Clin Cancer Res
; 37(1): 85, 2018 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-29665837
17.
The plasma Epstein-Barr virus DNA level guides precision treatment for nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: a large population-based cohort study from an endemic area.
Ther Adv Med Oncol
; 10: 1758835918782331, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30046357
18.
Effect of induction chemotherapy with cisplatin, fluorouracil, with or without taxane on locoregionally advanced nasopharyngeal carcinoma: a retrospective, propensity score-matched analysis.
Cancer Commun (Lond)
; 38(1): 21, 2018 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29764487
19.
Concurrent Chemoradiotherapy versus Intensity-modulated Radiotherapy Alone for Elderly Nasopharyngeal Carcinoma Patients with Pre-treatment Epstein-Barr Virus DNA: A Cohort Study in an Endemic Area with Long-term Follow-up.
J Cancer
; 9(17): 3023-3031, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30210624
20.
A phase II trial of induction NAB-paclitaxel and cisplatin followed by concurrent chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma.
Oral Oncol
; 70: 7-13, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28622892